Friday, July 6, 2012

Glaxo Smith Kline Admits Criminal Fraud




What is most disturbing is the willingness of corporations to outright bribe the medical profession and the willingness of that same profession to accept those bribes. At the end of the day, the doctor makes a biased choice between what he knows works and what he knows pays best. This is why chronic conditions remain chronic far too often.

I have personally resolved several conditions related to my own health over the years that were troublesome. On occasion I received useful information from my doctor and pretty good diagnostic information. Only once did a young doctor provide me with a cost effective tool that was effective. The ongoing lesson is that you are truly on your own when it comes to a wide range of ailments that are not intermediately life threatening.

What is most offensive is the constant twisting of the science to bad mouth effective protocols in place for centuries. Try and find them on a shelf somewhere. It is always possible to locate a doctor to glibly knock a treatment by simply misrepresenting the science itself. This opens the door for another authority to tout the positive claims of the commercial product.

In the end, it is all targeted at the 99% plus who are simply lacking critical thinking when it comes to supposed science – based claims.

GlaxoSmithKline admits to criminal pharma fraud in 3 billion dollar case

Wednesday, July 04, 2012 by: D Holt

(NaturalNews) British registered company, GlaxoSmithKline, faces $3 billion in penalties after pleading guilty to the biggest health care fraud case in history. GSK admitted that physicians had been bribed to push potentially dangerous drugs in exchange for Madonna tickets, Hawaiian holidays, cash and lucrative speaking tours. They also admitted distributing misleading information regarding the antidepressant Paxil. The report claimed that it was suitable for children, but failed to acknowledge data from studies proving its ineffectiveness in children and adolescents.


GSK faced charges that they had used the gifts to sell three drugs that were either unsafe, or used for purposes that were not approved. The first drug, Paxil also known as Seroxat, was touted as safe and effective for children and adolescents. The ineffectiveness of Paxil, and the link to suicides, meant that it was banned for kids under 18-years-olds in 2008.

The second drug, Avandia was used in Britain to treat diabetes until it was withdrawn due to safety fears, including increased risk of heart attacks. The US government claimed that GSK had attempted to conceal the data surrounding the dangers.


The third drug, Wellbrutin is used in the UK for treating depression, but it was alleged that GSK had recommended physicians used it for ADHD, lost libido and as a slimming aid. None of which were approved uses for the drug.

The moral code of Big Pharma companies exposed

Sir Andrew Witty, chief executive of GSK said "Whilst these offenses originate in a different era for the company, they cannot and will not be ignored. On behalf of GSK, I want to express our regret and reiterate that we have learned from the mistakes that were made. We are deeply committed to doing everything we can to live up to and exceed the expectations of those we work with and serve. In the US, we have taken action at all levels in the company. We have fundamentally changed our procedures for compliance, marketing and selling."


US attorney for Massachusetts, Carmen Ortiz said: "The GSK sales force bribed physicians to prescribe GSK products using every imaginable form of high priced entertainment, from Hawaiian vacations to paying doctors millions of dollars to go on speaking tours, to a European pheasant hunt, to tickets to Madonna concerts."


This is the biggest settlement in the history of drug industries, ahead of the 2009 Pfizer case in which it was fined $2.2 billion for promoting four drugs for unapproved uses. In 2010, GSK paid $96 million to a whistle-blower who exposed contamination problems and a management cover up in Puerto Rico.


The practice of pushing drugs for unapproved uses is endemic within the drug industries. Two of the largest drug companies have been caught and fined huge amounts for chasing sales targets using any means necessary. It proves that the health of customers, even children, ranks lower on the companies' agenda than profit. Using bribes to get doctors to prescribe drugs shows a complete lack of moral fiber from both sales teams and the doctors. After this case, surely the doctors also need to face the courts for their conduct.


Whilst the amounts of money seem to be a huge punishment for GSK, the settlement is merely a slap on the wrist for a company whose market value is $133 billion. Can we trust another multinational that promises to clean up its act, when others have promised the same, only to behave just as recklessly but much more surreptitiously.

Learn more: 

No comments: